Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis

Interferon beta (IFN-β) is the first line therapy of relapsing-remitting multiple sclerosis. IFN-β is a cytokine that can contribute to the development of systemic autoimmune disease including psoriasis. The development or the exacerbation of psoriasis during IFN-β treatment has been previously obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Toussirot, Éric, Béreau, Matthieu, Bossert, Marie, Malkoun, Imad, Lohse, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009278/
https://www.ncbi.nlm.nih.gov/pubmed/24839574
http://dx.doi.org/10.1155/2014/949317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009278/
https://www.ncbi.nlm.nih.gov/pubmed/24839574
http://dx.doi.org/10.1155/2014/949317

Ejemplares similares